Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
GeneDx Launches Program to Boost Access to Exome Testing for Pediatric Epilepsy Patients
In partnership with Biogen, Praxis Precision Medicines, and Stoke Therapeutics, the program will also contribute to GeneDx's rare disease database.
According to the company, its research into organoids and mouse models of Alzheimer's disease has resulted in the detection of roughly 800 proteoforms of the protein tau.
Esya Labs, Alamar Biosciences Partner on Biomarker Discovery Services
The companies will combine technologies to provide tailored assays for pharma firms developing therapies for neurological and inflammatory diseases.
Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations
Researchers trawled exome sequencing data to identify clinically actionable variants in 8 percent of cerebral palsy patients tested.
The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the Kiddose PGx test.